Amira Mahmoud Abd-elmonem
Giza, 12662, Egypt
NCT Number: NCT05575609
Type 1 diabetes mellitus is the most common chronic metabolic disorder in children. Diabetic children who take proper nutrition and good care attain normal growth status. Factors affecting growth in diabetic patients include gender, age at diagnosis, duration of disease, glycemic control, and puberty status. Moreover, diabetes mellitus has negative impact on vestibular system, affect proprioception and lower limb muscle fatigue resulting in reduced balance.
Looking for future studies?
Notify Me7 year–11 year
All sexes
Observational
Giza, 12662, Egypt
Limited literature is available regarding the relation between anthropometric measurements and balance in children with diabetes mellitus. Therefore, the current study will be conducted to investigate the relation between anthropometric measurements (weight, height and body mass index) and balance in children with diabetes mellitus.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
assessment of Relation between anthropometric measurements and balance in children with type 1 diabetes
Time frame: baseline assessment
HUMAC balance system will be used to assess balance
Time frame: baseline assessment
the anthropometric measurement will be conducted using universal weight scale
Time frame: baseline assessment
the anthropometric measurement will be conducted using universal height scale
Cairo University
Other
Relation Between Anthropometric Measurements and Balance in Children With Type 1 Diabetes
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT04066959
Autoimmune Diseases, Diabetes Mellitus
Detroit, Michigan, United States
View Trial DetailsNCT05669547
Autoimmune Diseases, Diabetes
Amersfoort, Netherlands
View Trial DetailsNCT04769167
Autoimmune Diseases, Cardiovascular Abnormalities
St Louis, Missouri, United States
View Trial DetailsNCT03406897
Autoimmune Diseases, Diabetes Mellitus
Miami, Florida, United States
View Trial Details